Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
July 13, 2008
Form 4
Source: SEC/Edgar
June 24, 2008
Form 4
Source: SEC/Edgar
June 24, 2008
Form 4
Source: SEC/Edgar
June 22, 2008
Form 4
Source: SEC/Edgar
June 17, 2008
Form 4
Source: SEC/Edgar
June 12, 2008
Form 4
Source: SEC/Edgar
May 11, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
May 08, 2008
Form 4
Source: SEC/Edgar
March 23, 2008
Form 4
Source: SEC/Edgar
March 23, 2008
Form 4
Source: SEC/Edgar
March 23, 2008
Form 4
Source: SEC/Edgar
March 20, 2008
Form 4
Source: SEC/Edgar
March 20, 2008
Form 4
Source: SEC/Edgar
March 19, 2008
Form 4
Source: SEC/Edgar
March 19, 2008
Form 4
Source: SEC/Edgar
March 19, 2008
Form 4
Source: SEC/Edgar
March 19, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
February 07, 2008
Form 4
Source: SEC/Edgar
December 20, 2007
Form 4
Source: SEC/Edgar
December 11, 2007
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.